EPISEEK™ to detect and monitor cancers.

A liquid biopsy is a simple and non-invasive alternative to surgical biopsies that provides physicians information about a tumor through a simple blood draw. Traces of the tumor’s DNA can be found in the blood (cell-free DNA) and can provide insights into the type of cancer, staging (disease progression) and which treatments are more likely to work. EPISEEK™ interrogates cancer specific aberrant DNA methylation cell-free DNA from the liquid biopsy for a proprietary set of biomarkers that always indicate the presence of cancer, as this molecular signature is not found on normal cells. Our technology is cost-effective, precise, may detect cancer earlier than imaging and is more accessible than a tissue biopsy.

Patent issued 2023.